Prescient Therapeutics
(ASX) PTX
Prescient Therapeutics Financials at a Glance
Market Cap
$58.88M
Revenue (TTM)
$6.13M
Net Income (TTM)
$15.93M
EPS (TTM)
$-0.01
P/E Ratio
-5.60
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$0.06
Volume
326,513
Open
$0.05
Price
$0.06
Volume
326,513
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.06
52-Week Range
$0.04 - $0.13
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$0.06
Volume
326,513
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.06
52-Week Range
$0.04 - $0.13
PTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Prescient Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Matthew James McDonnell
Website
www.ptxtherapeutics.comHeadquarters
Melbourne, VIC 3205, AU
PTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-54%
Return on Capital
-59%
Return on Assets
-48%
Earnings Yield
-17.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$58.88M
Shares Outstanding
1.05B
Volume
326.51K
Short Interest
0.00%
Avg. Volume
1.14M
Financials (TTM)
Gross Profit
$4.36M
Operating Income
$7.54M
EBITDA
$7.54M
Operating Cash Flow
$7.24M
Capital Expenditure
$0.00
Free Cash Flow
$7.24M
Cash & ST Invst.
$6.93M
Total Debt
$0.00
Prescient Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$58.88M
N/A
Market Cap/Employee
$19.63M
N/A
Employees
3
N/A
Net Income
$3.99M
-10.2%
EBITDA
$5.14M
+7.5%
Quarterly Fundamentals
Net Cash
$9.27M
-49.7%
Accounts Receivable
$5.70M
+143.8%
Inventory
$0.00
N/A
Long Term Debt
$445.94K
N/A
Short Term Debt
$49.94K
N/A
Return on Assets
-47.94%
N/A
Return on Invested Capital
-58.50%
N/A
Free Cash Flow
$6.54M
-87.8%
Operating Cash Flow
$6.54M
-87.8%